review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | C H Bridts | Q67508419 |
Margriet Faber | Q82145480 | ||
Vito Sabato | Q53737908 | ||
Didier G Ebo | Q57163261 | ||
P2093 | author name string | P G Jorens | |
J Leysen | |||
L S De Clerck | |||
S Swerts | |||
A Van Gasse | |||
P2860 | cites work | Hypersensitivity reactions to marijuana | Q24169791 |
Adverse effects of herbal drugs in dermatology | Q28143266 | ||
Cocaine-induced severe angioedema and urticaria | Q28369761 | ||
Urticaria induced by meperidine allergy | Q28375751 | ||
A study of skin sensitivity to various allergens by skin prick test in patients of nasobronchial allergy | Q33822134 | ||
Anaphylaxis during anesthesia in France: an 8-year national survey | Q34026551 | ||
Pharmacodynamics and pharmacokinetics of khat: a controlled study | Q34322352 | ||
Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity? | Q34454329 | ||
Addressing the Potential Risks Associated with Ephedra Use: A Review of Recent Efforts | Q34542608 | ||
Allergy to pholcodine: first case documented by oral challenge. | Q34555341 | ||
Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study | Q34563530 | ||
Chemistry of drug allergenicity. | Q34607699 | ||
Kava: an overview | Q35555096 | ||
Physicians' decisions to override computerized drug alerts in primary care | Q35593128 | ||
Cutaneous complications of intravenous drug abuse | Q35640367 | ||
Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells | Q37172061 | ||
Enlarged uvula (Quincke's Oedema)--a side effect of inhaled cocaine?--A case study and review of the literature | Q37216990 | ||
Anaphylactoid shock - a common cause of death in heroin addicts? | Q57267050 | ||
IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry | Q58617009 | ||
Purification and Structural Characterization of LTP1 Polypeptides from Beer | Q59133825 | ||
Identification of european allergy patterns to the allergen families PR-10, LTP, and profilin from Rosaceae fruits | Q37620243 | ||
Spice allergy | Q37923542 | ||
Extent of illicit drug use and dependence, and their contribution to the global burden of disease | Q37973812 | ||
Clinical and forensic signs related to cocaine abuse. | Q37978930 | ||
Occupational asthma due to different spices | Q38562818 | ||
Pathology of deaths associated with "ecstasy" and "eve" misuse | Q39582464 | ||
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents | Q40156899 | ||
Adverse reactions to intravenous codeine phosphate in children. A report of three cases | Q40268625 | ||
Plasma cell gingivitis apparently related to the use of khat: report of a case. | Q40467099 | ||
Mechanisms of activation of human mast cells and basophils by general anaesthetic drugs | Q40489795 | ||
Fever and urticaria to codeine | Q40622555 | ||
The safety of fentanyl use in the emergency department | Q42077724 | ||
Lipid transfer protein from Hevea brasiliensis (Hev b 12), a cross-reactive latex protein | Q42598226 | ||
Clinical value of morphine, pholcodine and poppy seed IgE assays in drug-abusers and allergic people | Q43487693 | ||
l-Ephedrine is a major constituent of Mao-Bushi-Saishin-To, one of the formulas of Chinese medicine, which shows immediate inhibition after oral administration of passive cutaneous anaphylaxis in rats. | Q43508183 | ||
Opiate-sensitivity: clinical characteristics and the role of skin prick testing | Q43684547 | ||
Uvular angioedema after intranasal cocaine consumption | Q44180418 | ||
Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol | Q44339399 | ||
Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin | Q44344285 | ||
Images in clinical medicine. Uvular angioedema (Quincke's disease). | Q44566074 | ||
New food allergies in a European non-Mediterranean region: is Cannabis sativa to blame? | Q44687584 | ||
Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). | Q44786403 | ||
Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release | Q44821942 | ||
Angioedema induced by tramadol--a potentially life-threatening condition | Q45229353 | ||
"Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series | Q45864178 | ||
Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively | Q46389637 | ||
Hypersensitivity myocarditis associated with ephedra use. | Q46621658 | ||
An unusual adverse reaction to tramadol | Q46705782 | ||
A 27-year-old woman with a swollen uvula, chest pain, and elevated creatinine phosphokinase levels | Q46717265 | ||
Death from a possible anaphylactic reaction to ecstasy | Q46764770 | ||
Anaphylaxis to intrathecal diamorphine. | Q47591889 | ||
Propofol and fentanyl induced perioperative anaphylaxis | Q48295947 | ||
Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. | Q48578539 | ||
Case report: fentanyl-associated intraoperative anaphylaxis with pulmonary edema | Q48609437 | ||
Pharmacological stimuli in asthma/urticaria | Q48649760 | ||
Allergic reaction associated with intravenous marijuana use. | Q51412066 | ||
Anaphylactic reaction to fentanyl or preservative. | Q51800948 | ||
Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl. | Q51815020 | ||
Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. | Q52289476 | ||
Sensitization to cross-reactive carbohydrate determinants and the ubiquitous protein profilin: mimickers of allergy. | Q52642758 | ||
Work-related contact urticaria to Cannabis sativa. | Q52852319 | ||
Inhaled heroin causing a life-threatening asthma exacerbation and marked peripheral eosinophilia. | Q53691278 | ||
Cannabis (hemp) positive skin tests and respiratory symptoms. | Q54179608 | ||
Relevance of the recombinant lipid transfer protein of Hevea brasiliensis: IgE-binding reactivity in fruit-allergic adults. | Q54450447 | ||
A case of hypersensitivity to pethidine in a woman in labour. | Q55646608 | ||
P433 | issue | 3 | |
P304 | page(s) | 307-318 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
P1476 | title | Allergy to illicit drugs and narcotics | |
P478 | volume | 44 |
Q41203380 | Basophil activation tests: a diagnostic break-through in opiate allergy |
Q38250069 | Basophil activation tests: time for a reconsideration. |
Q38547867 | Cannabis Allergy: What do We Know Anno 2015. |
Q40940984 | Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy. |
Q50064882 | The Risks and Benefits of Cannabis in the Dermatology Clinic |